Literature DB >> 32433131

The Application of a Venous Catheter for the Surgical Treatment of Punctal Occlusion.

Alessandro Meduri1, Leandro Inferrera1, Giuseppe Tumminello1, Gabriele Delia2, Marco Cicciù3, Pasquale Aragona1.   

Abstract

PURPOSE: Presentation about advantages of a new surgical technique in 20 patients with punctal occlusion with a venous catheter during punctoplasty.
METHODS: The arrangement of a 30-mm venous catheter used during puncoplasty surgery was performed in 10 patients with punctal occlusion. The venous catheter was removed after 15 to 45 days after surgery.
RESULTS: The use of the venous catheter supports the recanalization of the lacrimal drainage system 15 days after surgery. The venous catheter is easy to find, not expensive, and easy to use.
CONCLUSION: The technique is performed under regional anesthesia. Furthermore, after surgery, the recanalization of the lacrimal drainage system was observed with a significant reduction of the epiphora in 6 months after surgery.

Entities:  

Mesh:

Year:  2020        PMID: 32433131     DOI: 10.1097/SCS.0000000000006536

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  3 in total

1.  Repositioning of the Severe Prolapsed Silicone Tubes after Bicanalicular Nasal Intubation: A Novel Technique.

Authors:  Jinjing He; Jingwen Gong; Qingqing Zheng; Jin Jiang
Journal:  J Ophthalmol       Date:  2021-03-06       Impact factor: 1.909

2.  Assessment of Eyelid Pressure Using a Novel Pressure Measurement Device in Patients With Moderate-to-Severe Dry Eye Disease.

Authors:  Jingyi Wang; Jiayu Bao; Wenxiu Song; Siyuan Li; Yiran Hao; Lei Tian; Ying Jie
Journal:  Front Med (Lausanne)       Date:  2022-02-07

3.  A Comparison of Transcanalicular, Endonasal, and External Dacryocystorhinostomy in Functional Epiphora: A Minimum Two-Year Follow-Up Study.

Authors:  Can Ozturker; Bayasgalan Purevdorj; Gamze Ozturk Karabulut; Gamal Seif; Korhan Fazil; Yasser Anwar Khan; Pelin Kaynak
Journal:  J Ophthalmol       Date:  2022-03-23       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.